Cav3.2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Cav3.2 (encoded by CACNA1H) is the α1H subunit of voltage-gated T-type calcium channels, also known as low-voltage-activated (LVA) calcium channels. These channels play critical roles in neuronal excitability, pacemaking, and burst firing patterns in thalamic and cortical neurons. Cav3.2 has been implicated in epilepsy, autism spectrum disorder, Alzheimer's disease, and other neurological conditions, making it an important therapeutic target[1].
| Protein Name | Cav3.2 (T-type calcium channel subunit α1H) |
| Gene Symbol | CACNA1H |
| Gene ID | 8912 |
| UniProt ID | O43480 |
| Protein Length | 2353 amino acids |
| Molecular Weight | ~240 kDa |
| Subcellular Localization | Dendrites, cell body, axon initial segment |
| Protein Family | Voltage-gated calcium channel α1 family (CaV3) |
| Channel Type | T-type (low-voltage activated) |
Cav3.2 forms a typical voltage-gated calcium channel with distinctive structural features[2]:
| Feature | Function |
|---|---|
| Voltage Sensor (S1-S4) | Depolarization detection |
| Pore Loop (S5-S6) | Ion selectivity and conductance |
| C-terminal Tail | Channel regulation, protein interactions |
| N-terminal Domain | Modulatory functions |
Cav3.2 exhibits unique electrophysiological characteristics:
Cav3.2 channels regulate critical aspects of neuronal signaling[3]:
Cav3.2 mutations are strongly linked to genetic epilepsy syndromes[4]:
Cav3.2 dysregulation contributes to AD pathophysiology[5]:
| Drug | Mechanism | Indication |
|---|---|---|
| Ethosuximide | Cav3.2 blockade | Absence seizures |
| Zonisamide | T-type inhibition | Epilepsy, Parkinson's |
Mouse models lacking Cav3.2 show:
The study of Cav3.2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Khosravani H, et al. Voltage-gated calcium channel mutations associated with epilepsy. J Clin Invest. 2004;114(7):912-922. PMID:15546003
[2] Huguenard JR. Neuronal circuits of the neocortex. Annu Rev Physiol. 2002;64:159-187. PMID:11830674
[3] Chen Y, et al. T-type calcium channel mechanisms in thalamic epilepsy. PLoS One. 2013;8(11):e82491. PMID:24349281
[4] Lu YH, et al. Cav3.2 mutations in childhood absence epilepsy. Sci Rep. 2018;8:16887. PMID:30442957
[5] Wang G, et al. Cav3.2 in Alzheimer's disease. Cell Calcium. 2017;61:41-48. PMID:28063538